Aktienanalyse zu DENTSPLY SIRONA Inc (XRAY)XRAYDENTSPLY SIRONA Inc

DENTSPLY SIRONA Inc. is a diversified manufacturer of professional dental products and technologies. It develops, manufactures, and markets comprehensive solutions offering dental and oral health products, as well as other consumable medical devices. Its Connected Technology Solutions segment includes the design, manufacture and sales of its dental technology and equipment products. Its Essential Dental Solutions segment includes the development, manufacture and sales of the Company's value-added endodontic, restorative, and preventive consumable products and small equipment used by dental professionals for the treatment of patients. Its Orthodontic and Implant Solutions segment includes the design, manufacture, and sales of its various digital implant systems and dental implant products, digital dentures and digital orthodontic solutions. Its Wellspect Healthcare segment includes the design, manufacture, and sales of its continence care solutions for both urinary and bowel management. It operates in the Healthcare sector (DENTAL EQUIPMENT & SUPPLIES industry).

DENTSPLY SIRONA Inc (XRAY) is currently priced at $9.43, which is below the average analyst price target of $12. However, the stock has a high RSI of 70.26, indicating it may be overbought. The company reported a gross margin improvement to 54.90% in Q2 2026, but it also faced a revenue decline of 4.1% year-over-year. The main risk is the negative earnings trend, with a forward P/E of 6.33 suggesting potential undervaluation, but the recent downgrades from analysts indicate caution.

13 analysts cover XRAY: 8 rate it Buy, 4 Hold and 1 Sell. The average price target is 13.04.